931 related articles for article (PubMed ID: 30623622)
1. Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea.
Jang W; Kim Y; Han E; Park J; Chae H; Kwon A; Choi H; Kim J; Son JO; Lee SJ; Hong BY; Jang DH; Han JY; Lee JH; Kim SY; Lee IG; Sung IK; Moon Y; Kim M; Park JH
Ann Lab Med; 2019 May; 39(3):299-310. PubMed ID: 30623622
[TBL] [Abstract][Full Text] [Related]
2. Routine chromosomal microarray analysis is necessary in Korean patients with unexplained developmental delay/mental retardation/autism spectrum disorder.
Shin S; Yu N; Choi JR; Jeong S; Lee KA
Ann Lab Med; 2015 Sep; 35(5):510-8. PubMed ID: 26206688
[TBL] [Abstract][Full Text] [Related]
3. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal Aberrations in Pediatric Patients with Developmental Delay/Intellectual Disability: A Single-Center Clinical Investigation.
Hu T; Zhang Z; Wang J; Li Q; Zhu H; Lai Y; Wang H; Liu S
Biomed Res Int; 2019; 2019():9352581. PubMed ID: 31781653
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal Microarray With Clinical Diagnostic Utility in Children With Developmental Delay or Intellectual Disability.
Lee JS; Hwang H; Kim SY; Kim KJ; Choi JS; Woo MJ; Choi YM; Jun JK; Lim BC; Chae JH
Ann Lab Med; 2018 Sep; 38(5):473-480. PubMed ID: 29797819
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal microarray testing influences medical management.
Coulter ME; Miller DT; Harris DJ; Hawley P; Picker J; Roberts AE; Sobeih MM; Irons M
Genet Med; 2011 Sep; 13(9):770-6. PubMed ID: 21716121
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility and cost-effectiveness analysis of chromosome testing concomitant with chromosomal microarray of patients with constitutional disorders in a U.S. academic medical center.
Su M; Page S; Haag M; Swisshelm K; Hennerich D; Graw S; LeRoux J; Brzeskiewicz P; Svihovec S; Bao L
J Genet Couns; 2022 Apr; 31(2):364-374. PubMed ID: 34397147
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic yield of the chromosomal microarray analysis in turkish patients with unexplained development delay/ıntellectual disability(ID), autism spectrum disorders and/or multiple congenital anomalies and new clinical findings.
Akkus N; Cubuk PO
Mol Biol Rep; 2024 Apr; 51(1):577. PubMed ID: 38664339
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic Analysis of Korean Patients with Abnormal Chromosomal Microarray in Patients with Unexplained Developmental Delay/Intellectual Disability.
Kim HJ; Park CI; Lim JW; Lee GM; Cho E; Kim HJ
Yonsei Med J; 2018 May; 59(3):431-437. PubMed ID: 29611406
[TBL] [Abstract][Full Text] [Related]
10. Phenotype comparison among individuals with developmental delay/intellectual disability with or without genomic imbalances.
de Souza LC; Dos Santos AP; Sgardioli IC; Viguetti-Campos NL; Marques Prota JR; de Oliveira-Sobrinho RP; Vieira TP; Gil-da-Silva-Lopes VL
J Intellect Disabil Res; 2019 Nov; 63(11):1379-1389. PubMed ID: 30900361
[TBL] [Abstract][Full Text] [Related]
11. New insights in the interpretation of array-CGH: autism spectrum disorder and positive family history for intellectual disability predict the detection of pathogenic variants.
Cappuccio G; Vitiello F; Casertano A; Fontana P; Genesio R; Bruzzese D; Ginocchio VM; Mormile A; Nitsch L; Andria G; Melis D
Ital J Pediatr; 2016 Apr; 42():39. PubMed ID: 27072107
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
Ho KS; Wassman ER; Baxter AL; Hensel CH; Martin MM; Prasad A; Twede H; Vanzo RJ; Butler MG
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941670
[TBL] [Abstract][Full Text] [Related]
13. The usefulness of array comparative genomic hybridization in clinical diagnostics of intellectual disability in children.
Bartnik M; Wiśniowiecka-Kowalnik B; Nowakowska B; Smyk M; Kędzior M; Sobecka K; Kutkowska-Kaźmierczak A; Klapecki J; Szczałuba K; Castañeda J; Własienko P; Bezniakow N; Obersztyn E; Bocian E
Dev Period Med; 2014; 18(3):307-17. PubMed ID: 25182394
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal microarray in clinical diagnosis: a study of 337 patients with congenital anomalies and developmental delays or intellectual disability.
Sansović I; Ivankov AM; Bobinec A; Kero M; Barišić I
Croat Med J; 2017 Jun; 58(3):231-238. PubMed ID: 28613040
[TBL] [Abstract][Full Text] [Related]
15. Clinical Utility of a Comprehensive, Whole Genome CMA Testing Platform in Pediatrics: A Prospective Randomized Controlled Trial of Simulated Patients in Physician Practices.
Peabody J; Martin M; DeMaria L; Florentino J; Paculdo D; Paul M; Vanzo R; Wassman ER; Burgon T
PLoS One; 2016; 11(12):e0169064. PubMed ID: 28036350
[TBL] [Abstract][Full Text] [Related]
16. The clinical impact of chromosomal microarray on paediatric care in Hong Kong.
Tao VQ; Chan KY; Chu YW; Mok GT; Tan TY; Yang W; Lee SL; Tang WF; Tso WW; Lau ET; Kan AS; Tang MH; Lau YL; Chung BH
PLoS One; 2014; 9(10):e109629. PubMed ID: 25333781
[TBL] [Abstract][Full Text] [Related]
17. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.
Miller DT; Adam MP; Aradhya S; Biesecker LG; Brothman AR; Carter NP; Church DM; Crolla JA; Eichler EE; Epstein CJ; Faucett WA; Feuk L; Friedman JM; Hamosh A; Jackson L; Kaminsky EB; Kok K; Krantz ID; Kuhn RM; Lee C; Ostell JM; Rosenberg C; Scherer SW; Spinner NB; Stavropoulos DJ; Tepperberg JH; Thorland EC; Vermeesch JR; Waggoner DJ; Watson MS; Martin CL; Ledbetter DH
Am J Hum Genet; 2010 May; 86(5):749-64. PubMed ID: 20466091
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal Aberrations in Pediatric Patients With Moderate/Severe Developmental Delay/Intellectual Disability With Abundant Phenotypic Heterogeneities: A Single-Center Study.
Wu D; Wu Y; Lan Y; Lan S; Zhong Z; Li D; Zheng Z; Wang H; Ma L
Pediatr Neurol; 2023 Oct; 147():72-81. PubMed ID: 37566956
[TBL] [Abstract][Full Text] [Related]
19. Clinical Performance of an Ultrahigh Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
Ho KS; Twede H; Vanzo R; Harward E; Hensel CH; Martin MM; Page S; Peiffer A; Mowery-Rushton P; Serrano M; Wassman ER
Biomed Res Int; 2016; 2016():3284534. PubMed ID: 27975050
[TBL] [Abstract][Full Text] [Related]
20. Comparative Benchmarking of Optical Genome Mapping and Chromosomal Microarray Reveals High Technological Concordance in CNV Identification and Additional Structural Variant Refinement.
Barseghyan H; Pang AWC; Clifford B; Serrano MA; Chaubey A; Hastie AR
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
